title: Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour.
abstract: BACKGROUND
  Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be helpful in the diagnosis and monitoring the response to treatment.
  
  
  METHODS
  In this case of a 36 year old woman, the elevated hCG level at presentation was helpful in making a clinical diagnosis of OGCT in a patient too unwell to permit a tissue diagnosis. Cisplatin based combination chemotherapy produced an initial normalisation of the hCG level, but later in treatment the patient developed new cerebral lesions and a rising serum hCG suggestive of disease progression. Further investigations suggested that the CNS lesions were cerebral TB and that the low levels of hCG elevations was likely to be pituitary in origin. Chemotherapy treatment was continued along with anti-tuberculous therapy and 24 months after successful completion of therapy the patient remains disease free.
  
  
  CONCLUSIONS
  In the treatment of cancer patients it may be helpful to consider the potential non-malignant causes of new CNS lesions and that low hCG elevations may result from physiology rather than pathology in selected cases.
authors.affiliation: Department of Medical Oncology Imperial College Healthcare NHS Trust Charing Cross Hospital London, UK.
authors.forename: Serena
authors.initials: S
authors.lastname: Rakha
authors.forename: Clare
authors.initials: C
authors.lastname: Bayliss
authors.forename: Frances
authors.initials: F
authors.lastname: Sanderson
authors.forename: Richard
authors.initials: R
authors.lastname: Smith
authors.forename: Michael
authors.initials: M
authors.lastname: Seckl
authors.forename: Philip
authors.initials: P
authors.lastname: Savage
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006063:Chorionic Gonadotropin / Q000378:metabolism*; D018450:Disease Progression; D005260:Female; D006801:Humans; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000473:pathology; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010902:Pituitary Gland / Q000378:metabolism* / Q000473:pathology; D011379:Prognosis; D020306:Tuberculosis, Central Nervous System / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D006063:Chorionic Gonadotropin